Telomere length of tumor tissues and survival in patients with early stage non-small cell lung cancer

Molecular Carcinogenesis

Volumn 53, Issue 4, 2014, Pages 272-279

  Jeon, Hyo Sung ^a   Choi, Yi Young ^a   Choi, Jin Eun ^a   Lee, Won Kee ^a   Lee, Eungbae ^b   Yoo, Seung Soo ^b   Lee, Shin Yup ^b   Lee, Jaehee ^b   Cha, Seung Ick ^b   Kim, Chang Ho ^b   Park, Jae Yong ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Lung cancer; Survival; Telomere length

Indexed keywords

DNA POLYMERASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELOMERE SHORTENING;

LUNG CANCER; SURVIVAL; TELOMERE LENGTH;

BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; DNA PRIMERS; HUMANS; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TELOMERE;

EID: 84895785537     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21972     Document Type: Article

References (23)

1. Blasco MA. Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet 2005; 6:611-622.
2. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12:1133-1138.
3. Wong JM, Collins K. Telomere maintenance and disease. Lancet 2003; 362:983-988.
4. Shay JW, Zou Y, Hiyama E, et al. Telomerase and cancer. Hum Mol Genet 2001; 10:677-685.
5. Gilley D, Tanaka H, Herbert BS. Telomere dysfunction in aging and cancer. Int J Bioch Cell Biol 2005; 37:1001-1013.
6. Hahn WC. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 2003; 21:2034-2043.
7. Calcagnile O, Gisselsson D. Telomere dysfunction and telomerase activation in cancer-A paradoxical paradox? Cytogenet Genome Res 2007; 118:270-276.
8. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: A potential cancer predisposition factor. J Natl Cancer Inst 2003; 95:1211-1218.
9. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008; 99:1385-1389.
10. Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010; 304:69-75.
11. Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91:25-34.
12. Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase deficient mice. Cell 1999; 96:701-712.
13. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47.
14. Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000; 21:477-484.
15. Hayflick L, Moorhead P. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621.
16. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-4878.
17. Lee EB, Jin G, Lee SY, et al. TP53 mutations in Korean patients with non-small cell lung cancer. J Korean Med Sci 2010; 25:698-705.
18. Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97:527-538.
19. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406:641-645.
20. Iwama H, Ohyashiki K, Ohyashiki JH, et al. Telomere length and telomerase activity with age in peripheral blood cells obtained from normal individuals. Hum Genet 1998; 102:397-402.
21. Shirotani Y, Hiyama K, Ishioka S, et al. Alteration in length of telomeric repeats in lung cancer. Lung Cancer 1994; 11:29-41.
22. Hirashima T, Komiya T, Nitta T, et al. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer. Anticancer Res 2000; 20:2181-2187.
23. Frias C, Garcia-Aranda C, Juan CD, et al. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer. Lung Cancer 2008; 60:416-425.